1. Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease. Glassberg JA, Wang J, Cohen R, Richardson LD, DeBaun MR (2012) Acad Emerg Med 19(6): 664-72
    › Citation · 22687181 (PubMed) · PMC3375948 (PubMed Central)
  2. Prospects for primary stroke prevention in children with sickle cell anaemia. Jordan LC, Casella JF, DeBaun MR (2012) Br J Haematol 157(1): 14-25
    › Citation · 22224940 (PubMed) · PMC3400704 (PubMed Central)
  3. Nocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemia. Hollocks MJ, Kok TB, Kirkham FJ, Gavlak J, Inusa BP, DeBaun MR, de Haan M (2012) J Int Neuropsychol Soc 18(1): 168-73
    › Citation · 22114954 (PubMed) · PMC3729265 (PubMed Central)
  4. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, Garrett M, Hooper WC, Bean CJ, Debaun MR, Arking DE, Bhatnagar P, Casella JF, Keefer JR, Barron-Casella E, Gordeuk V, Kato GJ, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Hoppe C, Gladwin MT, Zhang Y, Steinberg MH (2012) Blood 120(9): 1961-2
    › Citation · 22936743 (PubMed) · PMC3433099 (PubMed Central)
  5. Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. Thangarajh M, Yang G, Fuchs D, Ponisio MR, McKinstry RC, Jaju A, Noetzel MJ, Casella JF, Barron-Casella E, Hooper WC, Boulet SL, Bean CJ, Pyle ME, Payne AB, Driggers J, Trau HA, Vendt BA, Rodeghier M, DeBaun MR (2012) Br J Haematol 159(3): 352-9
    › Citation · 22958163 (PubMed) · PMC3775590 (PubMed Central)
  6. High one year mortality in adults with sickle cell disease and end-stage renal disease. McClellan AC, Luthi JC, Lynch JR, Soucie JM, Kulkarni R, Guasch A, Huff ED, Gilbertson D, McClellan WM, DeBaun MR (2012) Br J Haematol 159(3): 360-7
    › Citation · 22967259 (PubMed) · PMC4562224 (PubMed Central)
  7. Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Bean CJ, Boulet SL, Ellingsen D, Pyle ME, Barron-Casella EA, Casella JF, Payne AB, Driggers J, Trau HA, Yang G, Jones K, Ofori-Acquah SF, Hooper WC, DeBaun MR (2012) Blood 120(18): 3822-8
    › Citation · 22966170 (PubMed) · PMC3488892 (PubMed Central)
  8. Enuresis associated with sleep disordered breathing in children with sickle cell anemia. Lehmann GC, Bell TR, Kirkham FJ, Gavlak JC, Ferguson TF, Strunk RC, Austin P, Rosen CL, Marshall MJ, Wilkey O, Rodeghier MJ, Warner JO, DeBaun MR (2012) J Urol 188(4 Suppl): 1572-6
    › Citation · 22910247 (PubMed) · PMC3722896 (PubMed Central)
  9. Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice. Pritchard KA, Feroah TR, Nandedkar SD, Holzhauer SL, Hutchins W, Schulte ML, Strunk RC, Debaun MR, Hillery CA (2012) Am J Respir Cell Mol Biol 46(3): 389-96
    › Citation · 22033263 (PubMed) · PMC3326430 (PubMed Central)
  10. Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion. Roberts DO, Covert B, Lindsey T, Edwards V, McLaughlin L, Theus J, Wray RJ, Jupka K, Baker D, Robbins M, DeBaun MR (2012) Immunohematology 28(1): 7-12
    › Citation · 22646143 (PubMed)